Navigation Links
Texas A&M researcher explains how embryo fights retroviral infection
Date:6/24/2010

COLLEGE STATION, June 24, 2010 Some viruses insert themselves into the host's DNA during infection in a process called retroviral integration, causing several diseases, including AIDS and cancer, notes a Texas A&M researcher who specializes in fetal diseases. However, stem cells that give rise to the early embryo and yolk sac fight back, inhibiting further infection by aggressively silencing the invading viral DNA, says Michael Golding of the Department of Veterinary Physiology and Pharmacology.

The work of the researcher was recently published in Cell Stem Cell.

Early mammalian embryos actually possess three stem cell lineages: ES (embryonic stem), TS (trophectoderm stem), and XEN (extraembryonic endoderm), which give rise to the fetus, placenta and yolk sac respectively, the Texas A&M researcher explains. Using the mouse as a model organism, Golding and his colleagues demonstrate that the mechanisms silencing gene expression are different between each of the three stem cell types.

"Much like a closed book cannot be read while an open book can, the DNA encoding genes can either be tightly wound up and silent or in a relaxed, open, active state," Golding explains. "The mechanisms that control this gene packaging are called epigenetic as they represent a level of regulation that is above or 'epi' to genetics."

The study shows "retroviral silencing in XEN cells is epigenetic in origin" and that "the three cell lineages of early mammalian embryo have vastly different viral silencing strategies as well as different capacities to suppress retroviral activity."

To examine the validity of a common assumption that these stem cells use similar mechanisms to silence retroviruses, Golding infected the mouse embryo stem cells with mouse leukemia virus (MLV) and monitored the virus' activity.

ES cells showed a progressive decline in virus activity, while TS cells had a constant level of virus activity. XEN cells, however, exhibited extremely aggressive and rapid silencing of virus activity, according to the study.

"Epigenetics is an exciting new field of research which is altering the way we think about fetal nutrition and exposure to environmental chemicals," Golding adds. "This discovery that all three stem cell types of the early embryo utilize slightly different mechanisms to control gene expression has profound implications for how we diagnose and treat fetal diseases."


'/>"/>

Contact: Keith Randall
keith-randall@tamu.edu
979-845-4644
Texas A&M University
Source:Eurekalert

Related medicine news :

1. Texas Health Dallas Launches Screening Program for Female Heart Disease
2. Saddle Up for a Healthier Trip to the Rodeo! BMI of Texas Offers Healthy Eating Advice for Rodeo-bound Texans
3. Pivot Networks and Brookside Technology Partners, Inc. Team to Broaden Managed IT Services Offering for Texas SMBs
4. Estes Audiology Awards Hearing Aids to Two Worthy Recipients in Central Texas
5. Texas Health Care Association: Meeting Texas Seniors Ongoing Care Needs Threatened by Looming State, Federal Funding Threats
6. Former Hospital and Office Buildings in Mesquite, Texas, up for Sealed Bid Auction from Sperry Van Ness Accelerated Marketing
7. Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana
8. Odessa Texas Cosmetic Dentist Sponsoring Marine Toys for Tots Program to Give Children in Need Free Toys for the Holidays
9. The Ensign Group Acquires Three Texas Skilled Nursing Facilities
10. Texas Health Harris Methodist Hospital Southlake Joins With U.S. Marine Corps Reserves Toys for Tots to Spread Holiday Cheer
11. Independent Ombudsman for Texas Youth Commission Resigns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... 29, 2017 , ... Phytomer USA is pleased to introduce Jennifer Smith as ... Smith’s role is to provide excellent customer service, support, training and knowledge to spa ... comes to Phytomer with a wealth of industry experience including roles as spa manager ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... (The National Campaign) announces its support for the Access to Contraception for ... Jeanne Shaheen (D-NH) and Rep. Jackie Speier (D-CA), will help to ensure that ...
(Date:4/28/2017)... ... , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today ... outlook as “stable.” At the same time, the ratings agency cautioned that the company’s ... below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to ...
(Date:4/28/2017)... ... 2017 , ... The Radiology Business Management Association (RBMA) is pleased ... board election process has been in place since the RBMA was founded in 1968 ... FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... release financial results for the first quarter 2017 after ... The Company,s management team will host a corresponding conference ... ET. Investors interested in listening to the ... for domestic callers or (703) 326-3030 for international callers, ...
(Date:4/19/2017)... , April 19, 2017 The Global ... Forecast to 2022 report has covered and analysed the potential ... information on market size, shares and growth factors. The report ... challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major ...
Breaking Medicine Technology: